- Home
- SMTK vs IMNN Comparison
SMTK vs IMNN Comparison
Compare SMTK & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTK
- IMNN
- Stock Information
- Founded
- SMTK 2009
- IMNN 1982
- Country
- SMTK United Kingdom
- IMNN United States
- Employees
- SMTK N/A
- IMNN N/A
- Industry
- SMTK
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- SMTK
- IMNN Health Care
- Exchange
- SMTK NYSE
- IMNN Nasdaq
- Market Cap
- SMTK 9.5M
- IMNN 15.1M
- IPO Year
- SMTK N/A
- IMNN 1985
- Fundamental
- Price
- SMTK $6.89
- IMNN $1.04
- Analyst Decision
- SMTK
- IMNN Strong Buy
- Analyst Count
- SMTK 0
- IMNN 1
- Target Price
- SMTK N/A
- IMNN $14.00
- AVG Volume (30 Days)
- SMTK 10.9K
- IMNN 649.0K
- Earning Date
- SMTK 08-12-2024
- IMNN 08-14-2024
- Dividend Yield
- SMTK N/A
- IMNN N/A
- EPS Growth
- SMTK N/A
- IMNN N/A
- EPS
- SMTK N/A
- IMNN N/A
- Revenue
- SMTK $43,000.00
- IMNN N/A
- Revenue This Year
- SMTK N/A
- IMNN N/A
- Revenue Next Year
- SMTK N/A
- IMNN N/A
- P/E Ratio
- SMTK N/A
- IMNN N/A
- Revenue Growth
- SMTK 43.33
- IMNN N/A
- 52 Week Low
- SMTK $4.88
- IMNN $0.48
- 52 Week High
- SMTK $13.00
- IMNN $3.65
- Technical
- Relative Strength Index (RSI)
- SMTK N/A
- IMNN 44.29
- Support Level
- SMTK N/A
- IMNN $1.09
- Resistance Level
- SMTK N/A
- IMNN $1.39
- Average True Range (ATR)
- SMTK 0.00
- IMNN 0.10
- MACD
- SMTK 0.00
- IMNN -0.01
- Stochastic Oscillator
- SMTK 0.00
- IMNN 12.50
About SMTK SMARTKEM INC
SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in a number of applications including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.
About IMNN Imunon Inc.
Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases.